Pulmonary pharmacology and therapeutics

Pulmonary pharmacology and therapeutics

Delivered dose with jet and mesh nebulisers during spontaneous breathing, noninvasive ventilation and mechanical ventilation using adult lung models
Arzu Ari, James B. Fink

ERJ Open Research Jul 2021, 7 (3) 00027-2021; DOI: 10.1183/23120541.00027-2021
Effect of β-blockers on the risk of COPD exacerbations according to indication of use: the Rotterdam Study
Leila Karimi, Lies Lahousse, Phebe De Nocker, Bruno H. Stricker, Guy G. Brusselle, Katia M.C. Verhamme

ERJ Open Research Apr 2021, 7 (2) 00624-2020; DOI: 10.1183/23120541.00624-2020
Study design of a randomised, placebo-controlled trial of nintedanib in children and adolescents with fibrosing interstitial lung disease
Robin Deterding, Matthias Griese, Gail Deutsch, David Warburton, Emily M. DeBoer, Steven Cunningham, Annick Clement, Nicolaus Schwerk, Kevin R. Flaherty, Kevin K. Brown, Florian Voss, Ulrike Schmid, Rozsa Schlenker-Herceg, Daniela Verri, Mihaela Dumistracel, Marilisa Schiwek, Susanne Stowasser, Kay Tetzlaff, Emmanuelle Clerisme-Beaty, Lisa R. Young

ERJ Open Research Apr 2021, 7 (2) 00805-2020; DOI: 10.1183/23120541.00805-2020
Identification and treatment of T2-low asthma in the era of biologics
Chris Kyriakopoulos, Athena Gogali, Konstantinos Bartziokas, Konstantinos Kostikas

ERJ Open Research Apr 2021, 7 (2) 00309-2020; DOI: 10.1183/23120541.00309-2020
Design and rationale of a randomised, double-blind trial of the efficacy and safety of pirfenidone in patients with fibrotic hypersensitivity pneumonitis
Evans R. Fernández Pérez, James L. Crooks, Jeffrey J. Swigris, Joshua J. Solomon, Michael P. Mohning, Tristan J. Huie, Matthew Koslow, David A. Lynch, Steve D. Groshong, Kaitlin Fier

ERJ Open Research Apr 2021, 7 (2) 00054-2021; DOI: 10.1183/23120541.00054-2021
INTREPID: single- versus multiple-inhaler triple therapy for COPD in usual clinical practice
David M.G. Halpin, Sally Worsley, Afisi S. Ismaila, Kai-Michael Beeh, Dawn Midwinter, Janwillem W.H. Kocks, Elaine Irving, Jose M. Marin, Neil Martin, Maggie Tabberer, Neil G. Snowise, Chris Compton

ERJ Open Research Apr 2021, 7 (2) 00950-2020; DOI: 10.1183/23120541.00950-2020
Anti-HSP47 siRNA lipid nanoparticle ND-L02-s0201 reverses interstitial pulmonary fibrosis in preclinical rat models
Yun Liu, Jian Liu, Alistair Quimbo, Fengcheng Xia, Jiping Yao, Jean-Pierre Clamme, Sonya Zabludoff, Jun Zhang, Wenbin Ying

ERJ Open Research Apr 2021, 7 (2) 00733-2020; DOI: 10.1183/23120541.00733-2020
Lung function improvements following inhaled indacaterol/glycopyrronium/mometasone furoate are independent of dosing time in asthma patients: a randomised trial
Jutta Beier, Henrik Watz, Zuzana Diamant, Jens M. Hohlfeld, Dave Singh, Pascale Pinot, Ieuan Jones, Hanns-Christian Tillmann

ERJ Open Research Apr 2021, 7 (2) 00425-2020; DOI: 10.1183/23120541.00425-2020
Lumacaftor/ivacaftor changes the lung microbiome and metabolome in cystic fibrosis patients
Anne H. Neerincx, Katrine Whiteson, Joann L. Phan, Paul Brinkman, Mahmoud I. Abdel-Aziz, Els J.M. Weersink, Josje Altenburg, Christof J. Majoor, Anke H. Maitland-van der Zee, Lieuwe D.J. Bos

ERJ Open Research Apr 2021, 7 (2) 00731-2020; DOI: 10.1183/23120541.00731-2020
High-dose glucocorticoid treatment of near-fatal bocavirus lung infection results in rapid recovery
Matthias Obenaus, Oliver Schildgen, Dirk Schürmann, Ann-Christin von Brünneck, Martin Janz, Ulrich Keller, Bernhard Gebauer, Johannes Schilling, Stefan Schwartz, Benedikt Weissbrich, Thomas Schneider, Jörg Hofmann, Stephan Mathas

ERJ Open Research Apr 2021, 7 (2) 00060-2021; DOI: 10.1183/23120541.00060-2021

Main menu

User menu

Search

Pulmonary pharmacology and therapeutics

Pages

Contact us